Is a complete RDY research report available?

No complete published report is available for Dr. Reddy's Laboratories Limited (RDY) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

RDY Stock Analysis, Forecast & Valuation

Market cap	9.9B
Revenue (ttm)	3.5B
Net income (ttm)	350.1M
EPS (ttm)	$0.42
Shares out	833M
P/E (trailing)	28.4x
P/E (forward)	23.5x
Dividend	$0.06 (0.55%)
Volume	2,335,441

Beta	0.26

Price target	$13.5	+14.5%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RDY indicators

Market & fundamental data

Available fields

277

Groups with data

Currency

INR

Showing 277 of 277 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001135951
Company name	Dr. Reddy's Laboratories Limited
Country	India
Country code	US
Cusip	256135203
Employees	27,527
Employees Change	-284%
Employees Change Percent	-1.02
Enterprise value	$9.9B
Exchange	NYSE
Financial currency	INR
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	90.42
Industry PE Fwd	14.46
Isin	US2561352038
Last refreshed	2026-07-30
Market cap	$9.9B
Market cap category	Mid-Cap
Price	$11.76
Price currency	USD
Rev Per Employee	127,246.02x
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	RDY
Website	https://www.drreddys.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.52%
EV Earnings	28.21x
EV Sales Forward	0.03x
EV/EBIT	36.2x
EV/EBITDA	19.99x
EV/FCF	44.38x
EV/Sales	2.82x
FCF yield	2.24%
Forward P/E	23.53x
P/B ratio	2.43x
P/E ratio	28.39x
P/S ratio	2.84x
PE Ratio10 Y	29.03x
PE Ratio3 Y	20.61x
PE Ratio5 Y	22.63x
PS Forward	0.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.85%
EBITDA Margin	26.91%
FCF margin	6.43%
Gross margin	50.18%
Gross Profit	$1.8B
Gross Profit Growth	-13.77%
Gross Profit Growth Q	-22.8%
Gross Profit Growth3 Y	2.82%
Gross Profit Growth5 Y	9.82%
Net Income	$350.1M
Net Income Growth	-41.72%
Net Income Growth Q	-68.72%
Net Income Growth Years	0%
Net Income Growth3 Y	-11.16%
Net Income Growth5 Y	14.06%
Pretax Margin	12.47%
Profit Margin	10%
Profit Per Employee	$12,720
Profitable Years	17
ROA	4.01
Roa5y	9.28
ROCE	6.17
ROE	8.84
Roe5y	17.3
ROIC	7.46
Roic5y	18.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.64%
Cagr15y	4.02%
Cagr1y	-19.57%
Cagr20y	7.73%
Cagr3y	-4.62%
Cagr5y	-0.88%
Div CAGR10	1.41%
Div CAGR3	-7.8%
Div CAGR5	2.81%
EPS Growth	-41.68
EPS Growth Q	-68.74
EPS Growth Years	0
EPS Growth3 Y	-11.21
EPS Growth5 Y	14
FCF Growth	-8.57%
FCF Growth3 Y	-25.64%
FCF Growth5 Y	16.57%
OCF Growth	-21.62%
OCF Growth10 Y	0.89%
OCF Growth3 Y	-13.42%
OCF Growth5 Y	14.06%
Revenue Growth	-0.92x
Revenue Growth Q	-5.56x
Revenue Growth Years	9x
Revenue Growth3 Y	8.25x
Revenue Growth5 Y	11.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.6
Assets	$6.1B
Cash	$861.2M
Current Assets	$3.1B
Current Liabilities	$1.6B
Debt	$761M
Debt EBITDA	$1.54
Debt Equity	$0.19
Debt FCF	$3.42
Equity	$4.1B
Interest Coverage	6.2
Liabilities	$2B
Long Term Assets	$3B
Long Term Liabilities	$350.7M
Net Cash	$100.2M
Net Cash By Market Cap	$1.01
Net Cash Growth	-47.49%
Net Debt EBITDA	$-0.2
Net Debt Equity	$-0.02
Net Debt FCF	$-0.45
Tangible Book Value	$2.8B
Tangible Book Value Per Share	$3.39
WACC	5.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.9
Inventory Turnover	2.11
Net Working Capital	$1.3B
Quick ratio	1.16
Working Capital	$1.5B
Working Capital Turnover	$0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.05%
Dividend Growth	-10.13%
Dividend Growth Years	0%
Dividend per share	$0.06
Dividend Years	26
Dividend Yield	0.55%
Ex Div Date	2026-07-24
Last Dividend	$0.06
Payout Frequency	Annual
Payout Ratio	15.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	42.96%
1Y total return	-19.56%
200-day SMA	13.71
3Y total return	-13.23%
50-day SMA	13.37
50-day SMA vs 200-day SMA	50under200
5Y total return	-4.34%
All Time High	16.89
All Time High Change	-30.38%
All Time High Date	2024-08-09
All Time Low	1
All Time Low Change	1,071.31%
All Time Low Date	2001-04-11
ATR	0.38
Beta	0.26
Ch YTD	-16.24
High	11.87
High52	15.67
High52 Date	2026-06-26
High52ch	-24.95%
Low	11.75
Low52	11.36
Low52 Date	2026-07-22
Low52ch	3.52%
Ma50ch	-12.02%
Premarket Change Percent	-0.34
Premarket Price	$11.69
Price vs 200-day SMA	-14.24%
RSI	31.92
RSI Monthly	39.75
RSI Weekly	37.01
Sharpe ratio	-0.81x
Sortino ratio	-0.85
Total Return	0.6%
Tr YTD	-15.78
Tr15y	80.74%
Tr1m	-23.12%
Tr1w	3.91%
Tr3m	-15.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	0
Analyst Ratings	Hold
Earnings EPS Estimate	$0.17
Earnings EPS Estimate Growth	-15
Earnings Revenue Estimate	925,530,000x
Earnings Revenue Estimate Growth	-7.17x
Operating Income	$371.9M
Operating Income Growth	-50.9
Operating Income Growth Q	-80.41
Operating Income Growth3 Y	-18.31
Operating Income Growth5 Y	2.26
Operating margin	10.62
Price target	$13.46
Price Target Change	$14.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	599,971,874%
Float Percent	72.03%
Net Borrowing	140,271,181.3
Shares Insiders	26.73%
Shares Institutions	65.2%
Shares Out	832,984,140
Shares Qo Q	-0.01%
Shares Yo Y	-0.05%
Short Ratio	6.76
Short Shares	3.06

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$219.3M
Adjusted OCF	427,123,031.2
Average Volume	3,023,485.2x
Bv Per Share	4.87
CAPEX	$-207.8M
Ch10y	34.83
Ch15y	65.35
Ch1m	-23.54
Ch1w	3.34
Ch1y	-20
Ch20y	286.5
Ch3m	-16.18
Ch3y	-14.55
Ch5y	-6.93
Ch6m	-11.71
Change	0.26%
Change From Open	0.09
Close	11.73
Days Gap	0.17
Depreciation Amortization	203,804,792.1
Dollar Volume	27,464,786.2
Earnings Date	2026-07-22
Earnings Time	bmo
EBIT	$272.8M
EBITDA	$494.2M
EPS	$0.42
F Score	5
FCF	$222.6M
FCF EV Yield	2.25x
FCF Per Share	$0.27
Financing CF	25,129,137
Fiscal Year End	March
Founded	1,984
Goodwill	134,337,756.3
Graham Number	6.71474
Graham Upside	-42.9
Income Tax	$90.7M
Investing CF	-449,331,386
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-07-22
Last Report Date	2026-06-30
Last Split Date	2024-11-05
Last Split Type	Forward
Last10k Filing Date	2026-05-29
Lynch Fair Value	$5.82
Lynch Upside	-50.5
Ma150	13.62
Ma150ch	-13.62%
Ma20	12.89
Ma20ch	-8.74%
Net CF	23,214,838
Next Earnings Date	2026-10-23
Open	11.75
Optionable	Yes
P FCF Ratio	44.66
P FCF Ratio SBC	45.33
P OCF Ratio	23.1
P OCF Ratio SBC	23.28
Position In Range	8.33
Post Close	11.76
Postmarket Change Percent	1.36
Postmarket Price	$11.92
Ppne	1,207,044,588.4
Pre Close	11.73
Price Date	2026-07-29
Price EBITDA	$20.12
Ptbv Ratio	3.52
Relative Volume	0.77x
Revenue	3,502,701,296x
SBC By Revenue	0.09x
Share Based Comp	3,289,209
Tax By Revenue	2.59x
Tax Rate	20.77%
Tr20y	343.18%
Tr6m	-11.23%
Volume	2,335,441
Z Score	5.29

Dr. Reddy's Laboratories Limited (RDY)

Coverage state: Market snapshot only — no published research

Generate the first RDY analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RDY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RDY indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RDY

Frequently asked questions